| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/07/2022 | 392.96% | Piper Sandler | $9 → $7 | Maintains | Overweight |
| 11/15/2022 | 40.85% | Barclays | $5 → $2 | Maintains | Equal-Weight |
| 08/30/2022 | 604.23% | Piper Sandler | $15 → $10 | Maintains | Overweight |
| 07/27/2022 | — | Raymond James | Initiates Coverage On | → Market Perform | |
| 04/28/2022 | 252.11% | JP Morgan | → $5 | Initiates Coverage On | → Neutral |
| 04/19/2022 | 252.11% | Barclays | $7 → $5 | Maintains | Equal-Weight |
| 09/28/2021 | 1590.14% | Oppenheimer | → $24 | Initiates Coverage On | → Outperform |
| 09/16/2021 | 1097.18% | Piper Sandler | → $17 | Initiates Coverage On | → Overweight |
What is the target price for Lilium (LILM)?
The latest price target for Lilium (NASDAQ: LILM) was reported by Piper Sandler on December 7, 2022. The analyst firm set a price target for $7.00 expecting LILM to rise to within 12 months (a possible 392.96% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Lilium (LILM)?
The latest analyst rating for Lilium (NASDAQ: LILM) was provided by Piper Sandler, and Lilium maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Lilium (LILM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lilium, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lilium was filed on December 7, 2022 so you should expect the next rating to be made available sometime around December 7, 2023.
Is the Analyst Rating Lilium (LILM) correct?
While ratings are subjective and will change, the latest Lilium (LILM) rating was a maintained with a price target of $9.00 to $7.00. The current price Lilium (LILM) is trading at is $1.42, which is out of the analyst's predicted range.